Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Pharming (NASDAQ:PHAR).
Lexicon Pharmaceuticals has a consensus price target of $7.20.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $1.5201 last updated September 25, 2024 at 6:01 PM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.